FDA Inspection 1306352 — Howard J. Rubenstein, MD
The FDA completed an inspection of Howard J. Rubenstein, MD on March 5, 2026 in Saraland, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saraland, AL (United States)
Additional Details
Clinical Investigator (CI)